Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
HCA Healthcare names Michael Schlosser chief clinical officer effective Sept. 1

HCA Healthcare names Michael Schlosser chief clinical officer effective Sept. 1

ReutersReuters2026/08/06 12:34
  • HCA Healthcare named Michael Schlosser executive vice president, chief clinical officer, effective Sept. 1, 2026.
  • Schlosser is senior vice president, chief transformation officer; previously group chief medical officer for the National Group.
  • He will succeed Michael Cuffe, who will step down Aug. 31; Cuffe will serve as executive consultant through February 2027.
  • Charles Gressle will become president of the new Ambulatory Operations Group on Sept. 1; he currently leads the East Florida Division.
  • Gressle will oversee physician services, urgent care, physician practice operations, surgery ventures within a network of more than 2,700 facilities.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Citadel Securities sounds the alarm: September “curse” combined with cheap options, short-term risk-reward in US stocks deteriorates sharply

September is typically the worst-performing month for U.S. stocks, with the S&P 500's average monthly return at its lowest point of the year. Currently, option prices are also at their cheapest level of the year—combining these two factors makes the risk-reward ratio of buying downside protection particularly attractive.

智通财经2026/08/31 22:56
Citadel Securities sounds the alarm: September “curse” combined with cheap options, short-term risk-reward in US stocks deteriorates sharply